Patient requests and attitude towards neuroleptics von Hoencamp, E., Knegtering, H., Kooy, U. S., Van Der Molen, A.E.G.M.

Volltext

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial von Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, Le, Salwender, H J, Sonneveld, P

Volltext

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia von Löwenberg, Bob, Ossenkoppele, Gert J, van Putten, Wim, Schouten, Harry C, Graux, Carlos, Ferrant, Augustin, Sonneveld, Pieter, Maertens, Johan, Jongen-Lavrencic, Mojca, von Lilienfeld-Toal, Marie, Biemond, Bart J, Vellenga, Edo, Kooy, Marinus van Marwijk, Verdonck, Leo F, Beck, Joachim, Döhner, Hartmut, Gratwohl, Alois, Pabst, Thomas, Verhoef, Gregor

Volltext

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analys... von Scheid, Christof, Sonneveld, Pieter, Schmidt-Wolf, Ingo G H, van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Salwender, Hans, Zweegman, Sonja, Blau, Igor Wolfgang, Vellenga, Edo, Weisel, Katja, Pfreundschuh, Michael, Jie, Kon-Siong, Neben, Kai, van de Velde, Helgi, Duehrsen, Ulrich, Schaafsma, M Ron, Lindemann, Walter, Kersten, Marie José, Peter, Norma, Hänel, Mathias, Croockewit, Sandra, Martin, Hans, Wittebol, Shulamiet, Bos, Gerard Mj, van Marwijk-Kooy, Marinus, Wijermans, Pierre, Goldschmidt, Hartmut, Lokhorst, Henk M

Volltext

Regulation of Vertebrate Nervous System Alternative Splicing and Development by an SR-Related Protein von Calarco, John A., Superina, Simone, O'Hanlon, Dave, Gabut, Mathieu, Raj, Bushra, Pan, Qun, Skalska, Ursula, Clarke, Laura, Gelinas, Danielle, van der Kooy, Derek, Zhen, Mei, Ciruna, Brian, Blencowe, Benjamin J.

Volltext

Cytarabine Dose for Acute Myeloid Leukemia von Löwenberg, Bob, Pabst, Thomas, Vellenga, Edo, van Putten, Wim, Schouten, Harry C, Graux, Carlos, Ferrant, Augustin, Sonneveld, Pieter, Biemond, Bart J, Gratwohl, Alois, de Greef, Georgine E, Verdonck, Leo F, Schaafsma, Martijn R, Gregor, Michael, Theobald, Matthias, Schanz, Urs, Maertens, Johan, Ossenkoppele, Gert J

Volltext

Microbial transglutaminases generate T cell stimulatory epitopes involved in celiac disease von Dekking, E.H.A., Van Veelen, P.A., de Ru, A., Kooy-Winkelaar, E.M.C., Gröneveld, T., Nieuwenhuizen, W.F., Koning, F.

Volltext

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia von Vellenga, Edo, van Putten, Wim, Ossenkoppele, Gert J., Verdonck, Leo F., Theobald, Matthias, Cornelissen, Jan J., Huijgens, Peter C., Maertens, Johan, Gratwohl, Alois, Schaafsma, Ron, Schanz, Urs, Graux, Carlos, Schouten, Harry C., Ferrant, Augustin, Bargetzi, Mario, Fey, Martin F., Löwenberg, Bob

Volltext

Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder von Schneeberger, Pauline E, Kortüm, Fanny, Korenke, Georg Christoph, Alawi, Malik, Santer, René, Woidy, Mathias, Buhas, Daniela, Fox, Stephanie, Juusola, Jane, Alfadhel, Majid, Webb, Bryn D, Coci, Emanuele G, Abou Jamra, Rami, Siekmeyer, Manuela, Biskup, Saskia, Heller, Corina, Maier, Esther M, Javaher-Haghighi, Poupak, Bedeschi, Maria F, Ajmone, Paola F, Iascone, Maria, Peeters, Hilde, Ballon, Katleen, Jaeken, Jaak, Rodríguez Alonso, Aroa, Palomares-Bralo, María, Santos-Simarro, Fernando, Meuwissen, Marije E C, Beysen, Diane, Kooy, R Frank, Houlden, Henry, Murphy, David, Doosti, Mohammad, Karimiani, Ehsan G, Mojarrad, Majid, Maroofian, Reza, Noskova, Lenka, Kmoch, Stanislav, Honzik, Tomas, Cope, Heidi, Sanchez-Valle, Amarilis, Gelb, Bruce D, Kurth, Ingo, Hempel, Maja, Kutsche, Kerstin

Volltext

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS von Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.

Volltext

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine von Pabst, Thomas, Vellenga, Edo, van Putten, Wim, Schouten, Harry C., Graux, Carlos, Vekemans, Marie-Christiane, Biemond, Bart, Sonneveld, Peter, Passweg, Jakob, Verdonck, Leo, Legdeur, Marie-Cecile, Theobald, Matthias, Jacky, Emanuel, Bargetzi, Mario, Maertens, Johan, Ossenkoppele, Gert Jan, Löwenberg, Bob

Volltext

Einlagige, wassergetragene Beschichtung für unbehandelte Substrate auf Polypropylen-Basis von BUGAJSKI, JAMES, CRETE, ILLINOIS 60417, US, KOOY, ROBERT, LANSING, ILLINOIS 60438, US, MOELLER, RAYMOND J., CEDAR LAKE, INDIANA 46303, US, JACKSON, MICHAEL L., LAGRANGE, ILLINOIS 60525, US

Volltext bestellen

Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model von Payne, Beth A, Ryan, Helen, Bone, Jeffrey, Magee, Laura A, Aarvold, Alice B, Mark Ansermino, J, Bhutta, Zulfiqar A, Bowen, Mary, Guilherme Cecatti, J, Chazotte, Cynthia, Crozier, Tim, de Pont, Anne-Cornélie J M, Demirkiran, Oktay, Duan, Tao, Kallen, Marlot, Ganzevoort, Wessel, Geary, Michael, Goffman, Dena, Hutcheon, Jennifer A, Joseph, K S, Lapinsky, Stephen E, Lataifeh, Isam, Li, Jing, Liskonova, Sarka, Hamel, Emily M, McAuliffe, Fionnuala M, O'Herlihy, Colm, Mol, Ben W J, Seaward, P Gareth R, Tadros, Ramzy, Togal, Turkan, Qureshi, Rahat, Vivian Ukah, U, Vasquez, Daniela, Wallace, Euan, Yong, Paul, Zhou, Vivian, Walley, Keith R, von Dadelszen, Peter

Volltext

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study von Löwenberg, Bob, Beck, Joachim, Graux, Carlos, van Putten, Wim, Schouten, Harry C., Verdonck, Leo F., Ferrant, Augustin, Sonneveld, Pieter, Jongen-Lavrencic, Mojca, von Lilienfeld-Toal, Marie, Biemond, Bart J., Vellenga, Edo, Breems, Dimitri, de Muijnck, Hilde, Schaafsma, Ron, Verhoef, Gregor, Döhner, Hartmut, Gratwohl, Alois, Pabst, Thomas, Ossenkoppele, Gert J., Maertens, Johan, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), German Austrian AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Volltext

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS von Ossenkoppele, G.J, Breems, D.A, Stuessi, G, Van Norden, Y, Bargetzi, M, Biemond, B.J, A von dem Borne, P, Chalandon, Y, Cloos, J, Deeren, D, Fehr, M, Gjertsen, B, Graux, C, Huls, G, Janssen, J.J.J.W, Jaspers, A, Jongen-Lavrencic, M, De Jongh, E, Klein, S.K, Van der Klift, M, Van Marwijk Kooy, M, Maertens, J, Micheaux, L, Van der Poel, M.W.M, Van Rhenen, A, Tick, L, Valk, P, Vekemans, M.C, Van der Velden, W.J.F.M, De Weerdt, O, Pabst, T, Manz, M, Lowenberg, B, Havelange, Vekemans, M.-C, Moors, I, Van Obberg, F, Maertens, J.A, Hodossy, B, Vansteenweghen, S, Lammertijn, L, Sonet, A, Triffet, A, Gjertsen, B.T, Passweg, J, Heim, D, Giovanni, San, Stuessi, Georg, Betticher, D, Spertini, O, Gregor, M, Hess, U, Manz, M.G, Van de Loosdrecht, A, Janssen, J.J.W.M, Van Esser, J.W.J, Brouwer, R.E, Van Lammeren-Venema, D, Levin, M.D, Tick, L.W, Legdeur, M.C.J.C, Vellenga, E, Hoogendoorn, M, Veelken, J.H, Von dem Borne, P.A, Schouten, H.C, Cornelissen, J, Wouters, B, Raaijmakers, H.G.M, Kuball, J

Volltext

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis von Versluis, Jurjen, MD, Hazenberg, Carin L E, MD, Passweg, Jakob R, Prof, van Putten, Wim L J, MSc, Maertens, Johan, Prof, Biemond, Bart J, MD, Theobald, Matthias, Prof, Graux, Carlos, Prof, Kuball, Jurgen, Prof, Schouten, Harry C, Prof, Pabst, Thomas, Prof, Löwenberg, Bob, Prof, Ossenkoppele, Gert, Prof, Vellenga, Edo, Prof, Cornelissen, Jan J, Prof

Volltext

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma von Lokhorst, Henk M, Schmidt-Wolf, Ingo, Sonneveld, Pieter, van der Holt, Bronno, Martin, Hans, Barge, Rene, Bertsch, Uta, Schlenzka, Jana, Bos, Gerard M.J, Croockewit, Sandra, Zweegman, Sonja, Breitkreutz, Iris, Joosten, Peter, Scheid, Christof, van Marwijk-Kooy, Marinus, Salwender, Hans-Juergen, van Oers, Marinus H.J, Schaafsma, Ron, Naumann, Ralph, Sinnige, Harm, Blau, Igor, Delforge, Michel, de Weerdt, Okke, Wijermans, Pierre, Wittebol, Shulamiet, Duersen, Ulrich, Vellenga, Edo, Goldschmidt, Hartmut, for Dutch-Belgian HOVON and German GMMG

Volltext

SU‐GG‐T‐523: Benchmarking of An MMLC for Intensity‐Modulated Proton Radiotherapy, with Emphasis On Secondary Neutron Dose von Daartz, J, Bangert, M, Engelsman, M, Bussière, M, Oelfke, U, Kooy, H

Volltext

Optimized beam planning for linear accelerator-based stereotactic radiosurgery von Lu, Hsiao-Ming, Kooy, Hanne M., Leber, Zach H., Ledoux, Robert J.

Volltext

Systematic prioritization of candidate genes in disease loci identifies TRAFD1 as a master regulator of IFN gamma signaling in Celiac disease von Graaf, A. van der, Zorro, M.M., Claringbould, A., Vosa, U., Aguirre-Gamboa, R., Li, C., Mooiweer, J., Ricano-Ponce, I., Borek, Z., Koning, F., Kooy-Winkelaar, Y., Sollid, L.M., Qiao, S.W., Kumar, V., Li, Y., Franke, L., Withoff, S., Wijmenga, C., Sanna, S., Jonkers, I.

Volltext bestellen